Optimal practice in neonatal parenteral nutrition
Neonatal parenteral nutrition at a glance: What is it? For whom is it? How is it applied?
- What: injection of nutrition into the bloodstream
- For whom: preterm and sick infants, who cannot suck-swallow at the same time and have an immature digestive tract
- How: sterile, safe, and according to European guidelines
Adequate nutritional intakes – especially during the first 1000 days of life – are essential for promoting growth and health, including long-term metabolic, cognitive, and neurodevelopmental outcomes. Parenteral nutrition (PN) is a feeding method that bypasses the digestive tract by delivering nutrients directly to the bloodstream. This is a bit similar to feeding the unborn through the umbilical cord. Babies born preterm need some time to establish nutrition intake via the gastrointestinal tract, therefore PN is the only alternative method for them to meet nutrient requirements. PN is also crucial in babies with illnesses affecting the digestive tract (e.g. congenital or acquired gut disorder like necrotising enterocolitis (NEC)).
More information on the administration and composition of PN as well as on associated benefits and risks can be found here and in our Factsheet “Parenteral nutrition for very preterm and ill babies”(for parents and lay audience). In addition, our Academy Factsheet provides an overview of this topic and is directed to healthcare professionals.
The position paper “Addressing the nutritional emergency of preterm birth – Optimal practice in neonatal parenteral nutrition” highlights the importance of parenteral nutrition as a life-saving treatment for very preterm and sick babies. It was developed during an EFCNI roundtable in Munich involving several experts from various countries discussing and exchanging views and ideas. This position paper was launched during the jENS congress 2019 in Maastricht. It is intended to serve as a supplement to the European ESPGHAN/ESPEN/ESPR/CSPEN guidelines, and as a driving force for the development and implementation of guidelines on a national level. It targets policymakers and hospital administrators but can also be used as a tool by parent representatives and healthcare professionals to convince decision-making bodies to support the delivery of appropriate, high-quality parenteral nutrition.
Calling for national implementation of the European guidelines on paediatric parenteral nutrition (PN), EFCNI sought to first investigate how PN is implemented in Germany and whether healthcare professionals adhere to general standards and requirements as recommended by the guidelines. Therefore, a network was formed with the Federal Association of German Hospital Pharmacists (ADKA) and the German Society for Neonatology and Paediatric Intensive Care (GNPI). EFCNI subsequently co-hosted a joint roundtable, involving an expert panel assembled from German-speaking universities and hospital pharmacies elaborating a survey to collect data on the implementation of the European guidelines in Germany.
In 2020, all German hospital pharmacies and several clinics with neonatal intensive care units were invited to take part. Questions were asked related to the implementation of the guidelines, reasons for deviating from them, but also organisational aspects such as the supply of PN, and the topic of parent information.
Survey findings in brief:
- Majority of respondents are aware of the guidelines and implement them
- However, supply with parenteral solutions on weekends is challenging, leading to deviations from hygiene standards
- Only a third of respondents have access to software that is necessary to calculate the nutrient requirements
- Although European guideline recommends preferring standardised over individualised solutions, only half of respondents use standardised solutions regularly
- The way how parents are informed is insufficient. They are mainly informed orally and directly after birth, which is a format that does not always respect their situation and needs
- The practice of PN partly differs from guideline recommendations, which calls for activities to promote a safe and recommended implementation.
EFCNI hosted two digital roundtables in January 2021, together with ADKA, GNPI, supported by Bundesverband „Das frühgeborene Kind“ e.V. (BVDfK; Federal association ‘The preterm born child’) and Berufsverband Kinderkrankenpflege e.V. (BeDK; Professional association for paediatric nursing). During these roundtables, well-known German-speaking experts discussed how identified barriers could be avoided and overcome in future. Based on the constructive exchange, best-practice recommendations were elaborated to support healthcare professionals in the implementation of the European guidelines on PN and adhering to them in their daily practice. In order to share these solutions with all healthcare professionals, the panel developed the document “Toolkit für die parenterale Ernährung von Früh- und kranken Neugeborenen – Von der Leitlinie in die multidisziplinäre Anwendung“ (Toolkit for parenteral nutrition of preterm and sick newborns – From guideline to multidisciplinary application):
June 2021 | Toolkit launched in German language | Download Toolkit |
November 2021 | Barrier analysis and toolkit presented as e-poster | Download e-Poster (DGPM) |
January 2022 | Scientific article published | Download Article (DE) |
March 2022 | Results of publication and project outcome presented as ePoster | Download e-Poster (ADKA) |
Why is parenteral nutrition important for preterm infants?
This factsheet, directed to healthcare professionals, provides an overview of the components of parenteral nutrition, highlights the difference between and the respective benefits of individualised and standardised parenteral nutrition and guides through the process from indication to administration. Furthermore, the barriers and risk management with regards to the implementation of parenteral nutrition as well as possibilities of communication with parents are presented.
The factsheet can be downloaded here free of charge.
What is parenteral nutrition and when do babies need it?
This factsheet, directed to parents, families and lay audience, explains how parenteral nutrition is administered, compares the benefits and risks, explains the composition of parenteral nutrition and shows what mothers can do while their baby needs this kind of nutrition therapy.
The factsheet can be downloaded here free of charge.
The use of standardised or individual parenteral nutrient (PN) solutions is a much-debated subject in neonatal clinical practice. In Sweden – when it comes to applying PN solutions in neonatal nutritional care – standardised solutions are already the standard approach. The individual PN solution is nevertheless used when patients require individualised nutritional care. In an interview with pharmacist Dr. Mattias Paulsson from Uppsala University Hospital, we had the opportunity to find out how this implementation process of standardised PN took place, what the reasons and the preconditions were to take this step, and how it affects the day-to-day running of clinical units. Learn more about this intriguing topic and watch the full interview.
Also available with German subtitles – auch mit deutschem Untertitel verfügbar!
When a baby is born preterm and has health problems, parents worry incessantly. This was also the case for Gigi Khonyongwa-Fernandez, whose son was in the NICU after being born in gestational week 24 and had to be fed parenterally. In addition to the worries about his development, there were also many questions about his treatment. In this interview, she shares her experiences and encourages parents and healthcare professionals to communicate openly with each other.
Find our playlist of interviews on parenteral nutrition here
The entire process of parenteral nutrition – from the indication to the composition of solutions until the administration – is accompanied by several challenges. Small inaccuracies can lead to severe problems such as infections, sepsis, liver problems and metabolic disturbances in babies. Therefore, implementation and consultation of guidelines is key for better care of preterm and sick newborns, as individual practices may not be in line with the current evidence!
Based on an interactive infographic and statements of two renowned experts in this field, Dr Mattias Paulsson and Prof Nadja Haiden, the relevance of an evidence-based, safe implementation of parenteral nutrition therapy for preterm and sick newborns is highlighted as part of the campaign“Did you know? Facts about parenteral nutrition”.
Interactive Infographic
Are you aware that there are European guidelines on pediatric parenteral nutrition which contain evidence-based recommendations across the entire provisioning process, from the indication to the composition of solutions until the administration?
This interactive infographic shows which evidence-based recommendations – from determining the need for parenteral nutrition to prevention of complications – are contained in the guidelines and should be implemented in everyday clinical practice to ensure the safe implementation of parenteral nutrition therapy for preterm and sick newborns.
Expert Statements
When it comes to parenteral nutrition for preterm or sick newborns, there are two approaches: individualised and standardised parenteral nutrition. According to clinical guidelines, using standardised solutions should be preferred over the use of individualised solutions, even for newborns with higher nutrient demands, like those with very low birth weight. For most preterm and sick newborns, standardised solutions can replace individualised formulas, covering the newborn’s needs effectively.
Parenteral nutrition expert Dr Mattias Paulsson emphasises in his statement the benefits of standardised parenteral nutrition and explains additional advantages.
In parenteral nutrition, nutrients are injected directly into the bloodstream, bypassing the digestive system. Therefore, intravenous access is established via special catheters. Ultimately, it is important to use the correct delivery site to avoid associated complications such as contamination, blockage of the catheter, problematic interactions of the applied solution and thrombosis, all of which can lead to serious comorbidities such as bloodstream infections or sepsis.
Parenteral nutrition expert Prof Nadja Haiden explains in her statement which delivery site should be preferred based on the current guideline recommendation.
Parenteral nutrition is a high-alert medication. It should be manufactured in qualified production facilities that ensure high quality standards to guarantee sterility, shelf life and ultimately balanced and safe nutritional support.
Parenteral nutrition expert Dr Mattias Paulsson emphasises in his statement the importance of a qualified administration to promote growth, recovery, and overall health in preterm and sick newborns.
Parenteral nutrition therapy for infants is administered via a catheter, whereby the application of the solutions is the responsibility of the nursing staff for reasons of hygiene. Due to these circumstances, there is still a misconception that parents cannot support their infant’s parenteral nutrition therapy.
Parenteral nutrition expert Prof Nadja Haiden explains in her statement why, contrary to this misconception, parents play a crucial role in their baby’s nutritional therapy and have a decisive influence on the overall success of the treatment.
Explanatory Video
Parenteral nutrition is a life-saving treatment for preterm or critically sick infants. Given the potential risks associated with this high-alert medication, a robust infrastructure is essential. This includes a multidisciplinary nutrition team that can effectively coordinate routine procedures and ensure optimal, safe and guideline-compliant parenteral nutrition.
This explanatory video outlines the individual steps from assessing needs to administration and targeted evaluation.
The roundtable, the position paper, the barrier analysis, and the corresponding toolkit are kindly supported by an educational grant by Baxter.